Research reference only. Not medical advice. Most compounds are not FDA-approved. These are research chemicals, not for human consumption. Consult a qualified clinician.Read methodology Terms update on 18 Dec 2026
← Back to Research Index
Compare Evaluate Matrix Half-Life
Dossier · № 61 of 110 Updated Nov 17, 2026

TB-500

Thymosin Beta-4 Fragment · Tβ4 fragment

ANECDOTAL + ANIMAL STUDIES · THYMOSIN Β4 FRAGMENT; TISSUE REPAIR

▓ 32 indexed citations across PubMed (19), ClinicalTrials.gov (1), EuropePMC (12).

Citation breakdown by evidence tier

← weaker evidence  ·  stronger evidence →

32 citations across 4 tiers

Tap any tier to jump to that section of the bibliography.

Background

TB-500 (Ac-LKKTETQ) is a synthetic heptapeptide that corresponds to the N-acetylated active fragment of the endogenous signalling factor thymosin beta-4. It is claimed to increase muscle growth and accelerate wound healing and tissue repair, reduce inflammation, and improve flexibility.

→ Wikipedia

Mechanism of action

Binds and sequesters G-actin; promotes actin polymerization; upregulates angiogenesis and cell migration

Researched effects

Actin regulation; angiogenesis; muscle/cardiac/wound repair; flexibility

Live evidence

Live signals refreshed daily. Current as of November 19, 2026.

Dosing reported in literature

2-2.5 mg SC/IM 2x weekly for 4-6 week load; then 2 mg monthly

→ Seeds WA, Peptide Protocols Vol 1 (TB-500 load + monthly maintenance); r/Peptides wiki consensus on injury-specific load + maintenance pattern

Known concerns

WADA-banned; limited human data; injection site pain; lethargy; theoretical proliferation concerns

Top-ranked picks

10 pre-curated authoritative sources, ranked by journal tier and study weight.

  1. TB-500 (Thymosin Beta 4 17-23 Fragment) for Cardiovascular Biomarkers in Stable ASCVD

    2026 — TRIAL REGISTRATIONS (CLINICALTRIALS.GOV) · AUTHORITY 71.5

  2. Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions.

    Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews · 2026 — REVIEWS · AUTHORITY 54.5

  3. Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians.

    The American journal of sports medicine · 2026 — REVIEWS · AUTHORITY 54.5

  4. Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance.

    Sports medicine (Auckland, N.Z.) · 2026 — REVIEWS · AUTHORITY 54.5

  5. Analytical approaches for the detection of emerging therapeutics and non-approved drugs in human doping controls.

    Journal of pharmaceutical and biomedical analysis · 2014 — REVIEWS · AUTHORITY 53.4

  6. Therapeutic peptides in gerontology: mechanisms and applications for healthy aging.

    Frontiers in aging · 2026 — REVIEWS · AUTHORITY 52.5

  7. Injuries, Injections, and Internet Forums: A Qualitative Study of Reddit User Perspectives on Peptide Therapy After Orthopaedic Surgery.

    2026 — RESEARCH ARTICLES · AUTHORITY 34.5

  8. Annual Banned-Substance Review 18th Edition-Analytical Approaches in Human Sports Drug Testing 2024/2025.

    2026 — RESEARCH ARTICLES · AUTHORITY 34.5

  9. Investigational Peptides in Orthopaedic Practice: Evidence, Safety, and Patient Counseling for BPC-157, Thymosin Beta-4, and TB-500.

    The Journal of the American Academy of Orthopaedic Surgeons · 2026 — RESEARCH ARTICLES · AUTHORITY 34.5

  10. Peptide Supplements and Their Therapeutic Applications in Sports Medicine.

    The American journal of sports medicine · 2026 — RESEARCH ARTICLES · AUTHORITY 34.5

Full citation library

Year distribution

Trial Registrations (ClinicalTrials.gov)

1
  1. 1.

    NCT07487363 · Phase 1/Phase 2 · Recruiting · 2026

    Conditions: Atherosclerotic Cardiovascular Diseases, Endothelial Dysfunction

Reviews

5
  1. 2.

    Rahman OF, Lee SJ, Seeds WA · Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews · 2026 · PMID 41490200

    Therapeutic peptides are emerging as promising adjuncts in the management of orthopaedic injuries, grounded in their ability to modulate molecular signaling networks central to cellular medicine. By acting on key pathways such as PI3K/Akt, mTOR, MAPK, TGF-β, and AMPK, peptides exert influence over tissue regeneration, inflammation resolution, and neuromuscular recovery. Wound-healing peptides such as BPC-157, TB-500, and GHK-Cu promote angiogenesis, integrin-mediated extracellular matrix remodel…

  2. 3.

    Mayfield CK, Bolia IK, Feingold CL, Lin EH, et al. · The American journal of sports medicine · 2026 · PMID 41476424

    Therapeutic peptides are short-chain amino acids that regulate cellular functions and facilitate biochemical processes. In recent years, there has been significant growth in the global market for therapeutic peptides and thus its popularity among patients. Given the increase in the development of peptides and increased marketing to patients for orthopaedic injuries, it is critical for orthopaedic surgeons to understand the current evidence behind these therapeutic peptides. To evaluate the curre…

  3. 4.

    Thevis M, Schänzer W · Journal of pharmaceutical and biomedical analysis · 2014 · PMID 24906629

    The number and diversity of potentially performance-enhancing substances is continuously growing, fueled by new pharmaceutical developments but also by the inventiveness and, at the same time, unscrupulousness of black-market (designer) drug producers and providers. In terms of sports drug testing, this situation necessitates reactive as well as proactive research and expansion of the analytical armamentarium to ensure timely, adequate, and comprehensive doping controls. This review summarizes l…

  4. 5.

    Mendias CL, Awan TM · Sports medicine (Auckland, N.Z.) · 2026 · PMID 41966639

    Peptides are short chains of amino acids with a unique pharmacological niche between small-molecule drugs and large proteins. Their use in sports medicine is rapidly expanding, driven by patient demand for accelerated injury recovery and performance enhancement. While numerous peptide drugs have undergone a rigorous approval process that evaluates both safety and efficacy, a parallel "gray market" of unapproved compounds has emerged, operating largely outside of regulatory oversight. Our objecti…

  5. 6.

    Mavrych V, Shypilova I, Bolgova O · Frontiers in aging · 2026 · PMID 42021992

    Peptide therapeutics represent an emerging frontier in gerontological medicine, targeting fundamental hallmarks of aging including metabolic dysfunction, telomere attrition, tissue repair impairment, and hormonal decline. To comprehensively review the mechanisms, clinical applications, evidence base, and safety profiles of therapeutic peptides with demonstrated or potential applications in healthy aging and age-related conditions. A comprehensive narrative review was conducted through systematic…

Research Articles

21
  1. 7.

    Rahaman KA, Muresan AR, Min H, Son J, et al. · Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2024 · PMID 38382158

    TB-500 (Ac-LKKTETQ), derived from the active site of thymosin β4 (Tβ4), has various biological functions in its unacetylated form, LKKTETQ. These functions include actin binding, dermal wound healing, angiogenesis, and skin repair. The biological effects of TB-500, however, have not been documented. And the analysis of TB-500 and its metabolites have been neither simultaneously quantified nor structurally identified using synthesized authentic standards. This study was aimed to investigating sim…

  2. 8.

    Esposito S, Deventer K, Goeman J, Van der Eycken J, et al. · Drug testing and analysis · 2012 · PMID 22962027

    The formulation TB-500 is suspected to be used as doping agent in sport. This work describes the detection and the identification of the N-terminal acetylated 17-23 fragment of human thymosin beta 4 (Ac-LKKTETQ) in TB-500 by means of high-performance liquid chromatography/high resolution mass spectrometry using an Orbitrap Exactive benchtop mass spectrometer. Ac-LKKTETQ was also synthesized by solid-phase peptide synthesis, and an analytical strategy for detection in plasma and urine by high-per…

  3. 9.

    Ho EN, Kwok WH, Lau MY, Wong AS, et al. · Journal of chromatography. A · 2012 · PMID 23084823

    A veterinary preparation known as TB-500 and containing a synthetic version of the naturally occurring peptide LKKTETQ has emerged. The peptide segment (17)LKKTETQ(23) is the active site within the protein thymosin β(4) responsible for actin binding, cell migration and wound healing. The key ingredient of TB-500 is the peptide LKKTETQ with artificial acetylation of the N-terminus. TB-500 is claimed to promote endothelial cell differentiation, angiogenesis in dermal tissues, keratinocyte migratio…

  4. 10.

    Ismael E, Kamel S, Elleithy EMM, Bekeer MR, et al. · Scientific reports · 2025 · PMID 40681595

    Sodium butyrate and tributyrin are known to enhance broiler chicken performance. In this study, 1,000 Arbor Acres broiler chicks were assigned to four dietary treatments (250 birds each; six replicates of 40-42 birds): a control basal diet (CON), or the same diet supplemented with either 500 g/ton tributyrin (40%) + copper + essential oils (TB-500), 300 g/ton di- and tri-butyrin (60%) (TB-300), or 500 g/ton coated sodium butyrate (40%) (SB-500). Weekly growth parameters were recorded, and on Day…

  5. 11.

    Thevis M, Thomas A, Schänzer W · Expert review of proteomics · 2014 · PMID 25382550

    With the growing availability of mature systems and strategies in biotechnology and the continuously expanding knowledge of cellular processes and involved biomolecules, human sports drug testing has become a considerably complex field in the arena of analytical chemistry. Proving the exogenous origin of peptidic drugs and respective analogs at lowest concentration levels in biological specimens (commonly blood, serum and urine) of rather limited volume is required to pursue an action against ch…

  6. 12.

    Judák P, Van Eenoo P, Deventer K · Analytical biochemistry · 2017 · PMID 28887173

    The tendency of peptides to adsorb to surfaces can raise a concern in variety of analytical fields where the qualitative/quantitative measurement of low concentration analytes (ng/mL-pg/mL) is required. To demonstrate the importance of using the optimal glassware/plasticware, four doping relevant model peptides (GHRP 5, TB-500, Insulin Lispro, Synachten) were chosen and their recovery from various surfaces were evaluated. Our experiments showed that choosing expensive consumables with low-bind c…

  7. 13.

    Kwok WH, Ho EN, Lau MY, Leung GN, et al. · Analytical and bioanalytical chemistry · 2013 · PMID 23318763

    In recent years, there has been an ongoing focus for both human and equine doping control laboratories on developing detection methods to control the misuse of peptide therapeutics. Immunoaffinity purification is a common extraction method to isolate peptides from biological matrices and obtain sufficient detectability in subsequent instrumental analysis. However, monoclonal or polyclonal antibodies for immunoaffinity purification may not be commercially available, and even if available, such an…

  8. 14.

    Esposito S, Deventer K, Geldof L, Van Eenoo P · Journal of peptide science : an official publication of the European Peptide Society · 2015 · PMID 25469748

    Peptide hormones represent an emerging class of potential doping agents. Detection of their misuse is difficult due to their short half-life in plasma and rapid elimination. Therefore, investigating their metabolism can improve detectability. Unfortunately, pharmacokinetic studies with human volunteers are often not allowed because of ethical constraints, and therefore alternative models are needed. This study was performed in order to evaluate in vitro models (human liver microsomes and S9 frac…

  9. 15.

    Thomas A, Görgens C, Guddat S, Thieme D, et al. · Journal of separation science · 2016 · PMID 26578461

    The analysis of low-molecular-mass peptides in doping controls has become a mandatory aspect in sports drug testing and, thus, the number of samples that has to be tested for these analytes has been steadily increasing. Several peptides <2 kDa with performance-enhancing properties are covered by the list of prohibited substances of the World Anti-Doping Agency including Desmopressin, LH-RH, Buserelin, Triptorelin, Leuprolide, GHRP-1, GHRP-2, GHRP-3, GHRP-4, GHRP-5,GHRP-6, Alexamorelin, Ipamoreli…

  10. 16.

    Zvereva I, Semenistaya E, Krotov G, Rodchenkov G · Journal of proteomics · 2016 · PMID 27569051

    Small peptides with a molecular weight of <2kDa represent a performance-enhancing substances. However, in vivo studies with human volunteers are limited because most of these peptides are not approved for human consumption. Thus, relevant in vitro models are a basic tool to study their metabolism for anti-doping purposes. To choose the best in vitro model the biotransformation of growth hormone releasing peptides (GHRPs), Desmopressin and TB-500 was investigated using various in vitro systems. H…

  11. 17.

    Semenistaya E, Zvereva I, Krotov G, Rodchenkov G · Drug testing and analysis · 2016 · PMID 26472487

    Currently liquid chromatography - mass spectrometry (LC-MS) analysis after solid-phase extraction (SPE) on weak cation-exchange cartridges is a method of choice for anti-doping analysis of small bioactive peptides such as growth hormone releasing peptides (GHRPs), desmoporessin, LHRH, and TB-500 short fragment. Dilution of urine samples with phosphate buffer for pH adjustment and SPE on weak cation exchange microelution plates was tested as a means to increase throughput of this analysis. Diluti…

  12. 18.

    Rosenberg AE, Taylor B, Rasquinha RD, Khan H, Quinn M, Marcaccio S, Lemme N. · 2026 · PMID 41877514

  13. 19.

    Liao HJ, Chen HT, Chang CH. · 2024 · PMID 39291443

    <h4>Objects</h4>Osteoarthritis (OA) is a widespread degenerative joint condition commonly occurring in older adults. Currently, no disease-modifying drugs are available, and safety concerns associated with commonly used traditional medications have been identified. In this review, a significant portion of research in this field is concentrated on cartilage, aiming to discover methods to halt cartilage breakdown or facilitate cartilage repair.<h4>Methods</h4>Researchers have mainly investigated t…

  14. 20.

    Thevis M, Kuuranne T, Geyer H. · 2026 · PMID 41702393

    Alongside the considerable advances and accomplishments in drug research and development, the breadth of anti-doping research topics has also continued to grow. This is particularly relevant not only to provide comprehensive information on new drug entities, drug metabolism and elimination, and/or the impact of administration and exposure routes on analytical test results but also to ensure the timely implementation of analytical methods that ensure the availability of relevant anti-doping testi…

  15. 21.

    Gómez-Guerrero NA, González-López NM, Zapata-Velásquez JD, Martínez-Ramírez JA, Rivera-Monroy ZJ, García-Castañeda JE. · 2022 · PMID 36340120

    Peptides are very diverse molecules that can participate in a wide variety of biological processes. In this way, peptides are attractive for doping, since these molecules can activate or trigger biological processes that can improve the sports performance of athletes. Peptide molecules are found in the official World Anti-Doping Agency lists, mainly in sections S2, S4, and S5. In most cases, these molecules have a very short half-life in the body and/or are identical to natural molecules in the…

  16. 22.

    Dai B, Liang H, Guo DD, Bi ZW, Yuan JL, Jin Y, Huan L, Guo XD, Cang M, Liu DJ. · 2019 · PMID 31906185

    Increased cashmere yield and improved quality are some goals of cashmere goat breeding. Thymosin beta-4 (Tβ4) plays a key role in the growth and development of hair follicles. For the past ten years, we have evaluated the role of Tβ4 by establishing a flock of 15 cashmere goats that specifically overexpress the <i>Tβ4</i> gene in the hair follicles. These Tβ4 overexpression (Tβ4-OE) cashmere goats had more secondary hair follicles than the WT goats and produced more cashmere. Meanwhile, combined…

  17. 23.

    Park B, Shin MH, Kim J, Park G, Ryu YK, Lee JW, Kim TJ, Moon EY, Lee KM. · 2021 · PMID 33468581

    Thymosin beta-4 (Tβ4) is an actin-sequestering peptide that plays important roles in regeneration and remodeling of injured tissues. However, its function in a naturally occurring pathogenic bacterial infection model has remained elusive. We adopted Tβ4-overexpressing transgenic (Tg) mice to investigate the role of Tβ4 in acute pulmonary infection and systemic sepsis caused by <i>Legionella pneumophila</i> Upon infection, Tβ4-Tg mice demonstrated significantly lower bacterial loads in the lung,…

  18. 24.

    Thevis M, Kuuranne T, Geyer H. · 2025 · PMID 39731401

    The 17th edition of the annual banned-substance review on analytical approaches in human sports drug testing is dedicated to literature published between October 2023 and September 2024. As in previous years, focus is put particularly on new or enhanced analytical options in human doping controls as well as investigations into the metabolism and elimination of compounds of interest, which represent central (while not exclusive) cornerstones of the global anti-doping mission. New information publ…

  19. 25.

    Tham A, Hodgkins CW, Kennedy JG · The Journal of the American Academy of Orthopaedic Surgeons · 2026 · PMID 42937313

    Peptide-based products, particularly Body Protection Compound-157 (BPC-157), and thymosin beta-4 (TB-4), and products marketed as TB-500, are increasingly promoted for musculoskeletal recovery despite limited clinical validation. This narrative review evaluated their molecular rationale, direct musculoskeletal evidence, human safety and efficacy data, product quality concerns, regulatory status, antidoping implications, and relevance to orthopaedic counseling. PubMed/MEDLINE, EMBASE, and Scopus…

  20. 26.

    Tewari K, Liu TP, Im C, Hamad C, et al. · The American journal of sports medicine · 2026 · PMID 42578445

    The peptide supplement market has experienced rapid growth due to marketing claims of enhanced performance and accelerated recovery from musculoskeletal injury. These peptides are increasingly popular with patients and athletes and are often perceived as low risk, despite the absence of efficacy or safety data for many emerging peptides. To summarize existing peer-reviewed data on 6 emerging peptides (BPC-157, thymosin beta-4 or TB-500, CJC-1295, MK-677, ipamorelin, and GHK-Cu [copper peptide])…

  21. 27.

    Biçer O, Adanir O, Güleryüz Y, Balci EC, et al. · Joint diseases and related surgery · 2026 · PMID 42542926

    This study aims to evaluate the effects of BPC-157, synthetic thymosin beta-4 (TB-500), and their combination on Achilles tendon healing using biomechanical, histopathological, histochemical, and immunohistochemical analyses in a rat model. Thirty-two male Sprague-Dawley rats, each aged 12 weeks and weighing approximately 330 g, underwent standardized Achilles tendon transection and repair and were randomly assigned to four groups, with eight rats in each group: control, BPC-157 (10 µg/kg/day),…

Preprints (not yet peer-reviewed)

5
  1. 28.

    McGuire F, Hughes E, Maak T, Cushman DM. · 2026

    Thymosin beta-4 (TB4) and the related compound commonly referred to as TB-500 are widely discussed in tissue healing and musculoskeletal medicine, but the scope and nature of the supporting literature remain unclear. We conducted a scoping review to map the evidence on TB4 and TB-500 in tissue healing, regeneration, and musculoskeletal repair. PubMed, Europe PMC, and ClinicalTrials.gov were searched through March 2026. English-language in vitro, animal, human, and registered clinical trial sourc…

  2. 29.

    Mendias CL, Awan TM. · 2026

    Peptides are short chains of amino acids with a unique pharmacological niche between small-molecule drugs and large proteins. Their use in sports medicine is rapidly expanding, driven by patient demand for accelerated injury recovery and performance enhancement. While numerous peptide drugs have undergone a rigorous approval process that evaluates both safety and efficacy, a parallel "gray market" of unapproved compounds has emerged, operating largely outside regulatory oversight. Our objective…

  3. 30.

    Mendias CL, Awan TM. · 2026

    Peptides are a rapidly expanding drug class with a parallel and largely unregulated gray market that sells preparations directly to consumers for self-administration. The use of gray market peptides has grown substantially, with patients self-administering these compounds for purported benefits including accelerated musculoskeletal injury recovery, muscle hypertrophy, fat loss, and athletic performance enhancement. The objective of this study was to evaluate the purity, measured abundance, and e…

  4. 31.

    Mendias CL, Awan TM. · 2025

    Peptides are short chains of amino acids with a unique pharmacological niche between small-molecule drugs and large proteins. Their use in sports medicine is rapidly expanding, driven by patient demand for accelerated injury recovery and performance enhancement. While numerous peptide drugs have undergone a rigorous approval process that evaluates both safety and efficacy, a parallel "gray market" of unapproved compounds has emerged, operating largely outside regulatory oversight. Our objective…

  5. 32.

    Cassinat J, Callan C, Liggett C, Wright V. · 2026

    <h4>Objective</h4> To describe how people use the unapproved peptides BPC-157 and TB-500 for tendon, ligament and muscle injury and what side effects they report. <h4>Methods</h4> Using a large language model validated against physician review, we analyzed 92,254 posts and comments from 28,652 users in Reddit’s peptide communities from 2021 to 2026. We compared side effects with those reported by users of four other peptides in the same communities. <h4>Results</h4> In all, 5,588 users described…

Curated sources on file

3
  1. 1.
  2. 2.
  3. 3.

Continue reading